Brief: Australian Clinical Labs Sees Low, Double-Digit EBIT Margins Achievable In Future
Feb 20 (Reuters) - Australian Clinical Labs Ltd
ACL.AX :
* CONTINUES TO BELIEVE LOW, DOUBLE-DIGIT EBIT MARGINS ARE
ACHIEVABLE INTO THE FUTURE
* EXPECTS NON-COVID REVENUE TO RETURN TO TREND GROWTH OVER
TIME
Source text for Eikon: ID:nASX3jWSQT
Further company coverage: ACL.AX
Recent news on Australian Clinical Labs
See all newsBrief: Australian Clinical Labs Appoints Deloitte As Auditor
Australia's Optiscan rises after imaging more than 80 cases in ACL study
Australian Clinical Labs falls to over two-week low on trading ex-dividend
Australian Clinical Labs at 6-month high on upbeat full-year results, guidance
Brief: Australian Clinical Labs Says It Expects FY27 Revenue Of A$745-765 Million